The U.K.’s AstraZeneca and Germany’s Bayer spend up to a combined $7.2 billion shoring up their portfolios. Laura Board reports from London.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
